SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-451861
Filing Date
2012-11-05
Accepted
2012-11-05 16:23:54
Documents
3
Period of Report
2012-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d435660d8k.htm 8-K 16429
2 PRESS RELEASE d435660dex991.htm EX-99.1 36887
3 GRAPHIC g435660g87t01.jpg GRAPHIC 3711
  Complete submission text file 0001193125-12-451861.txt   59735
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 121180330
SIC: 2834 Pharmaceutical Preparations